Form 8-K - Current report:
SEC Accession No. 0001062822-12-000016
Filing Date
2012-04-27
Accepted
2012-04-27 16:26:28
Documents
6
Period of Report
2012-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8-k04x26x2012.htm 8-K 66429
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION exh31amendedandrestatedcer.htm EX-3.1 55681
3 SECOND AMENDED AND RESTATED BYLAWS exh32secondamendedandresta.htm EX-3.2 162317
4 EQUITY INCENTIVE PLAN, AS AMENDED exh101equityincentiveplana.htm EX-10.1 91061
5 NON-EMPLOYEE DIRECTORS' EQUITY INCENTIVE PLAN, AS AMENDED exh102non-employeedirector.htm EX-10.2 64855
6 SUMMARY OF NON-EMPLOYEE DIRECTOR COMPENSATION exh103summaryofnon-employe.htm EX-10.3 6446
  Complete submission text file 0001062822-12-000016.txt   448172
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC./DE (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 12789943
SIC: 2834 Pharmaceutical Preparations